標(biāo)題: Titlebook: Bladder Disease; Research Concepts an Anthony Atala,Debra Slade Book 2003 Springer Science+Business Media, LLC, part of Springer Nature 200 [打印本頁(yè)] 作者: McKinley 時(shí)間: 2025-3-21 17:12
書(shū)目名稱Bladder Disease影響因子(影響力)
作者: Camouflage 時(shí)間: 2025-3-21 20:20
Interferon-α Response and Signal Transduction Pathway in Transitional Carcinoma Cell Linespapillomavirus infection, and bladder cancer.. About 53,000 patients are diagnosed with bladder cancer in the United States each year, and approximately 25% of these patents die from the disease annually.. Bacillus Calmette-Guerin (BCG) immunotherapy has been successfully used to treat superficial u作者: 最低點(diǎn) 時(shí)間: 2025-3-22 03:42
The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladderof 5-Aminolevulinic acid (5-ALA), a fluorescence cystoscopy for photodetection of tiny tumors in the bladder can be made. We investigated whether it is easier to recognize neoplasias or dysplasias of the bladder by fluorescence cystoscopy than it is to recognize them by conventional white light cyst作者: 蘑菇 時(shí)間: 2025-3-22 06:02
Detection of Her-2/Neu Cep 17 Mutations at Invasive Bladder Cancervior. Of superficial TCC (Ta, Tl), up to 70% will eventually be recurrent; 10 to 15% will progress to muscle invasion (≥ T2).. About 50% of patients with muscle-invasive bladder tumors subsequently develop metastases..作者: 極深 時(shí)間: 2025-3-22 11:16
KI67, P53, NM23, and DNA Cytometry IN Bladder Cancer: Potential Markers for Detection of Recurrence?re the most significant prognostic variables when planning treatment of TCC; however, the bladder tumor varies greatly in its biologic behavior. Up to 70% of superficial TCC (Ta/Tl) will eventually recur, while 10 to 15% will progress to muscle invasion (≥T2).. About 50% of patients with muscle-inva作者: 宣誓書(shū) 時(shí)間: 2025-3-22 16:34
The Effect of Contrast Material on Transitional Cell Carcinoma Viabilityures.. This concern is supported both by clinical studies showing a high rate of upper tract tumors in patients with bladder TCC and vesicoureteral reflux,. and by laboratory research demonstrating that many synchronous and metachronous tumors are monoclonal.. Many urologists, therefore, advocate av作者: 萬(wàn)神殿 時(shí)間: 2025-3-22 19:26
Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitionalhough PET has been in existence since the 1960s, it did not gain complete clinical acceptance until roughly a decade ago. At that time, Di Chiro et al demonstrated the ability of PET to differentiate between recurrent brain tumor and radiation necrosis.. This prompted the recognition of PET as a val作者: 舉止粗野的人 時(shí)間: 2025-3-22 22:27
Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder of functional organ preservation in long-term survivors (79% with complete remission (CR) after 5 years). Radiation bladders were rare at doses not exceeding 60 Gy. Age and co-morbidity were not exclusion criteria. Presence of a competent and cooperative radiotherapy department is a precondition to作者: 故意 時(shí)間: 2025-3-23 02:04 作者: Ondines-curse 時(shí)間: 2025-3-23 09:07 作者: HOWL 時(shí)間: 2025-3-23 12:59 作者: Anticoagulants 時(shí)間: 2025-3-23 14:11 作者: 輕快帶來(lái)危險(xiǎn) 時(shí)間: 2025-3-23 19:27
Grundbegriffe und Ma?st?be der Entlohnungeasing volume, but with a concurrent lack of increase in bladder pressure. The integration of both the active and passive elements determines the normal functional compliance of the bladder. Any alteration in either one of these elements can lead to abnormal bladder function.作者: COST 時(shí)間: 2025-3-24 01:59
https://doi.org/10.1007/978-3-322-82819-4 interventions for the treatment of bladder dysfunction associated with BPH requires an understanding of the pathological changes that occur in the underlying cellular mechanisms responsible for maintaining normal bladder function作者: demote 時(shí)間: 2025-3-24 02:57
Molecular Response of the Bladder to Obstructioneasing volume, but with a concurrent lack of increase in bladder pressure. The integration of both the active and passive elements determines the normal functional compliance of the bladder. Any alteration in either one of these elements can lead to abnormal bladder function.作者: 提名 時(shí)間: 2025-3-24 07:53
The Role of Lipids and Lipid Metabolites in Urinary Bladder Dysfunction Induced by Partial Outlet Ob interventions for the treatment of bladder dysfunction associated with BPH requires an understanding of the pathological changes that occur in the underlying cellular mechanisms responsible for maintaining normal bladder function作者: 黑豹 時(shí)間: 2025-3-24 12:32 作者: Dignant 時(shí)間: 2025-3-24 17:29
Wann man von einem Marktwert sprechen kann most who die of bladder cancer present with invasive disease.. Although patients with superficial TCC experience recurrence rates as high as 82%, the rate of progression to muscle-invasive disease or metastasis is only 10 to 15%..作者: Engulf 時(shí)間: 2025-3-24 22:06
Recent Developments in the Treatment of Bladder Cancer most who die of bladder cancer present with invasive disease.. Although patients with superficial TCC experience recurrence rates as high as 82%, the rate of progression to muscle-invasive disease or metastasis is only 10 to 15%..作者: 壟斷 時(shí)間: 2025-3-25 03:09
KI67, P53, NM23, and DNA Cytometry IN Bladder Cancer: Potential Markers for Detection of Recurrence?sive tumors subsequently develop metastases.. Therefore, biological characteristics influence, to a variable extent, the incidence of recurrence, disease-free time, stage progression, and metastatic diffusion of TCC.作者: 殘廢的火焰 時(shí)間: 2025-3-25 03:42 作者: fetter 時(shí)間: 2025-3-25 10:29
Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder preventing akinetic radiation bladders. Continuous life-long follow-up is necessary.. Cystectomy, together with modern urinary diversions, is still necessary; it is performed in non-responders and in patients with muscle-invasive recurrences.作者: grandiose 時(shí)間: 2025-3-25 13:20
Tumor Suppressor Genes of Bladder Cancer and Potential for Gene Therapydie from it.. The prognosis for patients with advanced tumors is poor, even for patients who receive aggressive multimodal therapy. Only 20 to 40% of patients with advanced bladder cancer survive 5 years.. Thus, novel treatments are needed to improve the prognosis for patients with bladder cancer.作者: 新字 時(shí)間: 2025-3-25 16:12 作者: 背心 時(shí)間: 2025-3-25 23:03
Wie sind die Wertsch?tzer zu ermitteln?sive tumors subsequently develop metastases.. Therefore, biological characteristics influence, to a variable extent, the incidence of recurrence, disease-free time, stage progression, and metastatic diffusion of TCC.作者: 閑蕩 時(shí)間: 2025-3-26 00:18
Zusammenfassung des dritten Teilsoiding any percutaneous approaches to TCC treatment or concomitant procedures at the time of transurethral bladder tumor resection; some investigators recommend administration of intravesical chemotherapy at the end of the endoscopic procedure to minimize the risk of tumor seeding..作者: 漸強(qiáng) 時(shí)間: 2025-3-26 05:31 作者: Lipoma 時(shí)間: 2025-3-26 11:24 作者: diabetes 時(shí)間: 2025-3-26 13:58
Jede Bewertung basiert auf PrognosenThe molecular heterogeneity of cancer suggests that simultaneous screening of a sample for different molecular markers is necessary in order to increase accuracy of cancer diagnosis. DNA chip technologies address this problem at the genomic level and provide accessibility to gene expression profiles.作者: affect 時(shí)間: 2025-3-26 18:07 作者: Negligible 時(shí)間: 2025-3-26 22:02
Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder CThe molecular heterogeneity of cancer suggests that simultaneous screening of a sample for different molecular markers is necessary in order to increase accuracy of cancer diagnosis. DNA chip technologies address this problem at the genomic level and provide accessibility to gene expression profiles.作者: Landlocked 時(shí)間: 2025-3-27 01:09 作者: needle 時(shí)間: 2025-3-27 05:23
Bladder Disease978-1-4419-8889-8Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: 自愛(ài) 時(shí)間: 2025-3-27 13:14
Wann man von einem Marktwert sprechen kannof 5-Aminolevulinic acid (5-ALA), a fluorescence cystoscopy for photodetection of tiny tumors in the bladder can be made. We investigated whether it is easier to recognize neoplasias or dysplasias of the bladder by fluorescence cystoscopy than it is to recognize them by conventional white light cystoscopy.作者: TAP 時(shí)間: 2025-3-27 14:55 作者: 姑姑在炫耀 時(shí)間: 2025-3-27 21:35 作者: 分貝 時(shí)間: 2025-3-27 22:39 作者: 堅(jiān)毅 時(shí)間: 2025-3-28 06:10
978-1-4613-4707-1Springer Science+Business Media, LLC, part of Springer Nature 2003作者: 來(lái)就得意 時(shí)間: 2025-3-28 09:36 作者: 核心 時(shí)間: 2025-3-28 11:11 作者: Grandstand 時(shí)間: 2025-3-28 16:13 作者: 胰臟 時(shí)間: 2025-3-28 21:48
Wann man von einem Marktwert sprechen kannvior. Of superficial TCC (Ta, Tl), up to 70% will eventually be recurrent; 10 to 15% will progress to muscle invasion (≥ T2).. About 50% of patients with muscle-invasive bladder tumors subsequently develop metastases..作者: fabricate 時(shí)間: 2025-3-28 22:58 作者: 不可侵犯 時(shí)間: 2025-3-29 03:24
Zusammenfassung des dritten Teilsures.. This concern is supported both by clinical studies showing a high rate of upper tract tumors in patients with bladder TCC and vesicoureteral reflux,. and by laboratory research demonstrating that many synchronous and metachronous tumors are monoclonal.. Many urologists, therefore, advocate av作者: 想象 時(shí)間: 2025-3-29 08:12
https://doi.org/10.1007/978-3-662-57562-8hough PET has been in existence since the 1960s, it did not gain complete clinical acceptance until roughly a decade ago. At that time, Di Chiro et al demonstrated the ability of PET to differentiate between recurrent brain tumor and radiation necrosis.. This prompted the recognition of PET as a val作者: gentle 時(shí)間: 2025-3-29 14:53
https://doi.org/10.1007/978-3-662-57562-8 of functional organ preservation in long-term survivors (79% with complete remission (CR) after 5 years). Radiation bladders were rare at doses not exceeding 60 Gy. Age and co-morbidity were not exclusion criteria. Presence of a competent and cooperative radiotherapy department is a precondition to作者: 草率女 時(shí)間: 2025-3-29 19:08
https://doi.org/10.1007/978-3-663-02666-2ed with a high rate of tumor recurrence despite treatment consisting of transurethral resection and intravesical chemotherapy or immunotherapy.. Tumor progression within 5 years occurs in 30 to 40% of patients with high-risk superficial disease; 15 to 34% of patients with superficial bladder cancer 作者: Lipoprotein(A) 時(shí)間: 2025-3-29 20:00 作者: Blazon 時(shí)間: 2025-3-30 00:46
https://doi.org/10.1007/978-3-322-82819-4ncluding urine retention, poor flow, nocturia, and detrusor instability. Over 80% of males 50 to 60 years of age and older have various degrees of bladder outlet obstruction secondary to BPH that results in urinary dysfunction.. The urinary dysfunction in men with BPH is related to functional,. stru作者: 小隔間 時(shí)間: 2025-3-30 04:02
https://doi.org/10.1007/978-3-322-82819-4y diseases, such as stroke, diabetes mellitus, and benign prostatic hyperplasia (BPH), as well as the ravages of advancing age, contribute to altered bladder function. While urinary incontinence is clearly a multifactorial disease, one prevalent manifestation, known as urge incontinence, is related 作者: Foolproof 時(shí)間: 2025-3-30 11:57
The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladderof 5-Aminolevulinic acid (5-ALA), a fluorescence cystoscopy for photodetection of tiny tumors in the bladder can be made. We investigated whether it is easier to recognize neoplasias or dysplasias of the bladder by fluorescence cystoscopy than it is to recognize them by conventional white light cystoscopy.作者: 膽小鬼 時(shí)間: 2025-3-30 14:07
Detection of Her-2/Neu Cep 17 Mutations at Invasive Bladder Cancervior. Of superficial TCC (Ta, Tl), up to 70% will eventually be recurrent; 10 to 15% will progress to muscle invasion (≥ T2).. About 50% of patients with muscle-invasive bladder tumors subsequently develop metastases..作者: Explicate 時(shí)間: 2025-3-30 17:34
Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitionalhough PET has been in existence since the 1960s, it did not gain complete clinical acceptance until roughly a decade ago. At that time, Di Chiro et al demonstrated the ability of PET to differentiate between recurrent brain tumor and radiation necrosis.. This prompted the recognition of PET as a valid method of tumor imaging.作者: 造反,叛亂 時(shí)間: 2025-3-31 00:09
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/b/image/189030.jpg作者: 攀登 時(shí)間: 2025-3-31 03:48
Book 2003rch are addressed, including oncology and ceIlular biology, neurophysiology, neurogenic bladder andincontinence, immunology, inflammation and infection, muscle, matrix and obstruction, and new frontiers and therapies of the bladder. Assembled in one publication, these papers and their findings demon作者: 沒(méi)有貧窮 時(shí)間: 2025-3-31 09:05 作者: painkillers 時(shí)間: 2025-3-31 11:22 作者: Control-Group 時(shí)間: 2025-3-31 17:06
Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bla
